-The Economic Times   China has outperformed India in tackling the "double-burden" of diseases that includes infectious diseases affecting the poor on the one hand and chronic lifestyle ailments typical of fast urbanisation on the other, a WHO report has said. While India's life expectancy has shot up to 65 years in 2009, up from 61 years in 2000, China has improved the same to 74 years during the last 10 years. Besides,...

Progress has been made on key MDG health targets, but non-infectious diseases have spread to developing countries The world is experiencing a change in the geographic distribution of diseases. Traditionally, infectious diseases, which claim the lives of so many children, have affected poor countries and non-communicable diseases, such as diabetes, cardiac ailments and cancer, have plagued rich countries. But the latest statistics released by the World Health Organisation (WHO) on Friday show...

The world is experiencing a change in the geographic distribution of diseases. Traditionally, infectious diseases, which claim the lives of so many children, affected poor countries, and noncommunicable diseases like diabetes, cardiac ailments and cancer plagued rich countries. But the latest statistics released by the World Health Organisation (WHO) Friday show that the income level of nations is no longer so important, and that all countries now face the burden of...

An increasing number of countries face a double burden of disease as the prevalence of risk factors for chronic diseases such as diabetes, heart diseases and cancers increase and many nations still struggle to reduce maternal and child deaths caused by infectious diseases, according to a United Nations statistical health report released today. “This evidence really shows that no country in the world can address health from either an infectious disease...

Says it receives far more submissions than the space to publish British medical journal The Lancet has refused to publish India's rebuttal in connection with an article in which a drug-resistant superbug was named after New Delhi. The National Centre for Disease Control (NCDC), in the rebuttal, disagreed with the naming of the bacteria as New Delhi Metallo Beta-lactamase-1. However, Lancet Editor Richard Horton, while on a visit to India later, apologised...